摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

丁氧基乙氧基乙酸钠 | 67990-17-4

中文名称
丁氧基乙氧基乙酸钠
中文别名
2-(2-丁氧基乙氧基)-乙酸钠盐(1:1)
英文名称
Acetic acid, (2-butoxyethoxy)-, sodium salt
英文别名
sodium;2-(2-butoxyethoxy)acetate
丁氧基乙氧基乙酸钠化学式
CAS
67990-17-4
化学式
C8H15NaO4
mdl
——
分子量
198.19
InChiKey
JOWTZKYGHSPYKA-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.32[at 20℃]
  • LogP:
    -1.89 at 20℃
  • 物理描述:
    Liquid

计算性质

  • 辛醇/水分配系数(LogP):
    -3.43
  • 重原子数:
    13
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    58.6
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • Microbubble formation using ultrasound
    申请人:——
    公开号:US20030032879A1
    公开(公告)日:2003-02-13
    Disclosed herein are agents for enhancing the contrast in a diagnostic ultrasound procedure. These agents comprise colloidal dispersions of the liquid-in-liquid type, i.e., emulsions or microemulsions, in which the dispersed liquid phase has a boiling point at or below the body temperature of the organism to be studied and thus undergoes a phase change from a dispersed liquid to a highly echogenic dispersed gaseous foam or kugelschaum following administration to an organism. The liquid state of the dispersed phase allows one to manufacture extremely stable, pharmaceutically acceptable emulsions with particle sizes typically below 1000 nm. The gaseous state at body temperature yields highly echogenic microbubbles, typically below 10,000 nm in diameter, which are effective as ultrasound contrast agents. Intravenous, intraarterial, oral, intraperitoneal, and intrauterine dosage forms, methods of administration, and imaging techniques are described.
    本文公开了一种增强诊断超声成像对比度的药剂。这些药剂包括液体-液体型胶体分散液,即乳液或微乳液,其中分散液相在被检测生物体的体温以下沸点,因此在给生物体注射后从分散液体相转变为高声学对比度的分散气态泡沫或库格尔沙。分散相的液态使得可以制造粒径通常低于1000纳米的极其稳定的药用乳剂。体温下的气态产生高声学对比度的微泡,直径通常低于10,000纳米,有效作为超声对比剂。描述了静脉、动脉内、口服、腹腔内和子宫内剂量形式、给药方法和成像技术。
  • Polymerization of silicone microemulsions
    申请人:——
    公开号:US20020091193A1
    公开(公告)日:2002-07-11
    Emulsions and latexes containing polymer particles with a diameter greater than 0.02 micron are prepared by (i) forming a microemulsion containing particles of oligomers with a diameter less than 0.02 micron by combining water, a surfactant, a hydride functional organosilicon oligomer or a mixture of such oligomers, and an alkenyl functional organosilicon oligomer or a mixture of such oligomers; (ii) adding a catalyst to the microemulsion; (iii) initiating polymerization of the oligomers; and (iv) continuing polymerization until an emulsion or latex is formed containing polymer particles with a diameter greater than 0.02 micron.
    制备直径大于0.02微米的聚合物颗粒的乳液和乳胶的方法为:(i)通过将、表面活性剂、含有氢化功能的有机寡聚体或混合物以及烯基功能的有机寡聚体或混合物组合形成直径小于0.02微米的寡聚体颗粒的微乳液;(ii)向微乳液中加入催化剂;(iii)启动寡聚体的聚合反应;(iv)继续聚合反应,直到形成直径大于0.02微米的聚合物颗粒的乳液或乳胶。
  • Process for removal of sealants from surfaces
    申请人:AMCHEM PRODUCTS, INC.
    公开号:EP0095312A1
    公开(公告)日:1983-11-30
    Processes for removing contaminating sealants used in the automobile and allied industries from water-insoluble surfaces, employing cleaning compositions which are aqueous solutions containing at least one C5-C9 alkanoic acid, normally at a concentration of at least 0.8 g/l and preferably 2.5 - 150 g/l, above all 8 - 60 g/l, as well as optionally other ingredients, notably at least 0.1 g/l and preferably 6 130 g/l of alkali metal phosphate or condensed phosphate. Aqueous compositions for use in the processes may be prepared by dilution of 10% - 25% of aqueous concentrates, usually containing solubility-enhancing agents.
    用于清除汽车和相关工业中用于不溶性表面的污染性密封剂的工艺,采用的清洗组合物为溶液,含有至少一种 C5-C9 烷酸,通常浓度至少为 0.8 克/升,最好为 2.5 - 150 克/升,最重要的是 8 - 60 克/升,以及可选的其他成分,特别是至少 0.1 克/升,最好为 6 130 克/升的碱磷酸盐或缩合磷酸盐。 工艺中使用的性组合物可以通过稀释 10%-25%的性浓缩物来制备,通常含有溶解性增强剂。
  • A process for phosphatizing and use thereof
    申请人:HENKEL CORPORATION (a Delaware corp.)
    公开号:EP0151813A2
    公开(公告)日:1985-08-21
    Aqueous compositions containing as essential ingredients; an alkanolamine, an aliphatic carboxylic acid containing 5 to 18 carbon atoms, and an arylenetriazole have been found effective in removing resin-containing sealants from the surfaces of zinc containing metals, such as galvanized steel, without causing changes in the surfaces of the metal, so that phosphate coatings which are subsequently applied to said surfaces are neither streaky nor spotty.
    研究发现,含有烷醇胺、含 5 至 18 个碳原子的脂肪族羧酸和芳烯三唑作为基本成分的性组合物,能有效去除含属(如镀钢)表面上的含树脂密封剂,而不会导致属表面发生变化,从而使随后涂在所述表面上的磷酸盐涂层既不会出现条纹,也不会有斑点。
  • A method of preserving ophthalmic solutions and compositions therefor
    申请人:CIBA-GEIGY AG
    公开号:EP0354186A1
    公开(公告)日:1990-02-07
    A preservative for ophthalmic solutions having an active ingredient is provided, having a hydrogen peroxide content of about 0.001 % to about 0.10 % by weight; and diethylene triamine penta(methylene phosphonic acid), or a physiologically compatible salt thereof, present at about 0.002 % to 0.03 % by weight and/or 0.005 % to about 0.20 % by weight of 1-hydroxyethylidene-1,1-diphosphonic acid, or a physiologically compatible salt thereof.
    提供了一种用于具有活性成分的眼科溶液的防腐剂,其过氧化氢含量约为 0.001 % 至约 0.10 %(按重量计);二亚乙基三胺五亚甲基膦酸或其生理相容盐的含量约为 0.002 % 至 0.03 %(按重量计)和/或 0.005 % 至约 0.20 %(按重量计),1-羟基亚乙基-1,1-二膦酸或其生理相容盐的含量约为 0.002 % 至 0.03 %(按重量计)和/或 0.005 % 至约 0.20 %(按重量计)。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸